Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AK130 in combination with AK112 for advanced pancreatic cancer is currently in the recruitment phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AK112
• AK130

Snippet

Sponsor: Akeso | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING